Follow
Mario Salvi
Mario Salvi
Head, Graves' Orbitopathy Center, Endocrinology, Fondazione IRCCS Cà Granda, Milan, Italy
Verified email at mariosalvinet.it
Title
Cited by
Cited by
Year
The 2016 European Thyroid Association/European Group on Graves' orbitopathy guidelines for the management of Graves' orbitopathy
L Bartalena, L Baldeschi, K Boboridis, A Eckstein, GJ Kahaly, C Marcocci, ...
European thyroid journal 5 (1), 9-26, 2016
9682016
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
L Bartalena, L Baldeschi, A Dickinson, A Eckstein, P Kendall-Taylor, ...
European Journal of Endocrinology 158 (3), 273-285, 2008
8492008
Teprotumumab for thyroid-associated ophthalmopathy
TJ Smith, GJ Kahaly, DG Ezra, JC Fleming, RA Dailey, RA Tang, ...
New England Journal of Medicine 376 (18), 1748-1761, 2017
6092017
Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy
L Bartalena, L Baldeschi, AJ Dickinson, A Eckstein, P Kendall-Taylor, ...
Thyroid 18 (3), 333-346, 2008
5792008
Teprotumumab for the treatment of active thyroid eye disease
RS Douglas, GJ Kahaly, A Patel, S Sile, EHZ Thompson, R Perdok, ...
New England Journal of Medicine 382 (4), 341-352, 2020
4642020
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study
M Salvi, G Vannucchi, N Currò, I Campi, D Covelli, D Dazzi, S Simonetta, ...
The Journal of Clinical Endocrinology & Metabolism 100 (2), 422-431, 2015
3872015
SARS-CoV-2-related atypical thyroiditis
I Muller, D Cannavaro, D Dazzi, D Covelli, G Mantovani, A Muscatello, ...
The lancet Diabetes & endocrinology 8 (9), 739-741, 2020
3272020
Treatment of Graves’ disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study
M Salvi, G Vannucchi, I Campi, N Curro, D Dazzi, S Simonetta, P Bonara, ...
European journal of endocrinology 156 (1), 33-40, 2007
3212007
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy
L Bartalena, GE Krassas, WM Wiersinga, C Marcocci, M Salvi, ...
The Journal of Clinical Endocrinology & Metabolism 97 (12), 4454-4463, 2012
3042012
Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha
E Roti, R Minelli, T Giuberti, S Marchelli, C Schianchi, E Gardini, M Salvi, ...
The American journal of medicine 101 (5), 482-487, 1996
2871996
Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking
M Salvi, M Pedrazzoni, G Girasole, N Giuliani, R Minelli, JR Wall, E Roti
European Journal of Endocrinology 143 (2), 197-202, 2000
1922000
Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease
M Salvi, G Girasole, M Pedrazzoni, M Passeri, N Giuliani, R Minelli, ...
The Journal of Clinical Endocrinology & Metabolism 81 (8), 2976-2979, 1996
1861996
Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression
M Salvi, G Vannucchi, I Campi, S Rossi, P Bonara, F Sbrozzi, C Guastella, ...
European journal of endocrinology 154 (4), 511-517, 2006
1842006
European Group on Graves’ Orbitopathy (EUGOGO). The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy Guidelines for the Management of Graves’ Orbitopathy
L Bartalena, L Baldeschi, K Boboridis, A Eckstein, GJ Kahaly, C Marcocci, ...
Eur Thyroid J 5 (1), 9-26, 2016
1792016
Outcome of orbital decompression for disfiguring proptosis in patients with Graves’ orbitopathy using various surgical procedures
MP Mourits, HM Bijl, MA Altea, L Baldeschi, K Boboridis, N Currò, ...
British Journal of Ophthalmology 93 (11), 1518-1523, 2009
1582009
Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement
P Perros, L Hegedüs, L Bartalena, C Marcocci, GJ Kahaly, L Baldeschi, ...
Orphanet journal of rare diseases 12, 1-6, 2017
1572017
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial
GJ Kahaly, M Riedl, J König, S Pitz, K Ponto, T Diana, E Kampmann, ...
The Lancet Diabetes & Endocrinology 6 (4), 287-298, 2018
1442018
Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid‐associated ophthalmopathy
M Salvi, A Miller, JR Wall
FEBS letters 232 (1), 135-139, 1988
1291988
Corneal involvement in Graves' orbitopathy: an in vivo confocal study
E Villani, F Viola, R Sala, M Salvi, C Mapelli, N Curro, G Vannucchi, ...
Investigative ophthalmology & visual science 51 (9), 4574-4578, 2010
1152010
Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities
M Salvi, ZG Zhang, D Haegert, M Woo, A Liberman, L Cadarso, JR Wall
The Journal of Clinical Endocrinology & Metabolism 70 (1), 89-94, 1990
1151990
The system can't perform the operation now. Try again later.
Articles 1–20